Momenta Pharma (MNTA) Posts Q3 Loss of $0.38, Tops by 2c
MNTA Hot Sheet
Revenue Growth %: -69.1%Financial Fact:
Interest income: 307K
Today's EPS Names:
TARO, BRLI, TLB, More
Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) reports Q3 loss of $0.38, 2 cents better than the analyst estimate of ($0.40). Revenue for the quarter was $4 million, which compares to the estimate of $4.74 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Semtech Corp (SMTC) Misses Q1 EPS by 4c; Guides Q2
- Talbots, Inc. (TLB) Posts Surprise Q1 Profit; Comps Dip 3.8%
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
